Á¤±âÇмú´ëȸ
¼ö¸é±³À°°­ÁÂ
»çÀüµî·Ï¾È³»
»çÀüµî·Ï
»çÀüµî·ÏÇöȲ
ÃÊ·ÏÁ¢¼ö
ÃÊ·ÏÁ¢¼ö¾È³»
±¸¿¬ ¹× Æ÷½ºÅÍ
Á¦À۾ȳ»
ÃÊ·ÏÁ¢¼ö
ÃʷϼöÁ¤
Çà»çÀå¾È³»
 

2009³âµµ Á¦4ȸ ´ëÇѼö¸éÇÐȸ Á¤±âÇмú´ëȸ

ÀϽÃ: 2009³â 11¿ù 21ÀÏ(Åä) ¿ÀÀü 7:50~¿ÀÈÄ5:50ºÐ
Àå¼Ò: ¼­¿ï ¹é¹ü±â³ä°ü
½Ã°£
ÄÁº¥¼Ç Ȧ
´ëȸÀǽÇ
±³À°Àå2
  Early morning session
07:50-08:50
CPAP and BiPAP in practice
ÁÂÀå:ÃÖ¼öÀü(ÀÎÁ¦´ë ³»°ú)
Year in review
ÁÂÀå:À±Àοµ(¼­¿ï´ë Á¤½Å°ú)
Portable devices for OSA diagnosis
ÁÂÀå:ÀÌÀç¼­
(¼­¿ï´ë À̺ñÀÎÈÄ°ú)¡¡
07:50-08:10 Indication of CPAP and titration guideline
¢¹ ¾ç±¤ÀÍ(¼øõÇâ´ë ½Å°æ°ú)
Melatonin and chronobiology
¢¹ Á¤±ÔÀÎ(°¡Å縯´ë Á¤½Å°ú)
What is the portable device, compared with full PSG?
¢¹ Á¤±â¿µ(°í·Á´ë ½Å°æ°ú)
08:10-08:30 Indication of BiPAP and titration guideline
¢¹ ±èÁöÇö(´Ü±¹´ë ½Å°æ°ú)
Cognitive effect of sleep loss
¢¹ ±èÁöÇö(°í·Á´ë ½Å°æ°ú)
Clinical evidences of portable devices in diagnosis for OSAS
¢¹ À̽ÂÈÆ(°í·Á´ë À̺ñÀÎÈÄ°ú)
08:30-08:50 Compliance of CPAP and BiPAP
¢¹ ÀÌ°üÈ£(¿µ³²´ë ³»°ú)
Neuroimages in sleep disorder
¢¹ ÁÖÀº¿¬(¼º±Õ°ü´ë ½Å°æ°ú)
Review of available portable devices in korea
¢¹ ±èÁ¤ÈÆ(¼­¿ï´ë À̺ñÀÎÈÄ°ú)
09:00-10:00 Invited Lecture 1
ÁÂÀå:È«½ÂºÀ(¼º±Õ°ü´ë ½Å°æ°ú)
- -
CBT for insomnia : recent developments and innovations
¢¹ Charles Morin
(Universite Laval, Canada)
10:00-10:30 Coffee Break
  Symposium I
 
Sleep apnea update
ÁÂÀå:¿°È£±â(ÀÎÁ¦´ë ³»°ú)
Insomnia(English Session)
ÁÂÀå:È«½Âö(°¡Å縯´ë Á¤½Å°ú)
Genetics of sleep disorders
ÁÂÀå:½Åö(°í·Á´ë È£Èí±â³»°ú)

10:30-10:50

CO2 modulation therapy in sleep apnea
¢¹ À±Ã¢È£(ÀÎÇÏ´ë ½Å°æ°ú)
Prevalence of insomnia in korea
¢¹ È«½Âö(°¡Å縯´ë Á¤½Å°ú)
OSAS
¢¹ ½Åö(°í·Á´ë È£Èí±â³»°ú)
10:50-11:10 Impact of obesity on sleep apnea
¢¹ Á¤¼®ÈÆ(¿ï»ê´ë Á¤½Å°ú)
Cardiovascular consequences of insomnia
¢¹ ±èÁöÇö(´Ü±¹´ë ½Å°æ°ú)
Narcolepsy
¢¹ ÀÓÇö±¹(°¡Å縯´ë Á¤½Å°ú)
11:10-11:30 Cardiovascular disorders and sleep apnea
¢¹ ÃÖ¼öÀü(ÀÎÁ¦´ë ³»°ú)
CBT and medication for the management of chronic insomnia
¢¹ Charles Morin(Universite Laval, Canada )
RLS
¢¹ ±è¸í±Ô(Àü³²´ë ½Å°æ°ú)
11:30-11:50
Åä·Ð
Åä·Ð
Åä·Ð
11:50-13:00 ÃÑȸ ¹× Áß½Ä
13:00-13:40 Invited Lecture 2
ÁÂÀå:ÀÌöÈñ(¼­¿ï´ë À̺ñÀÎÈÄ°ú)
- -
Homeostatic and circadian modulation of cognitive performance
¢¹ ÀÌÁ¤Èñ(°­¿ø´ë Á¤½Å°ú)
13:40-14:40 Oral Presentation 1(English)
ÁÂÀå:ÀÌÁ¤Èñ(°­¿ø´ë Á¤½Å°ú)
Oral Presentation 2
ÁÂÀå:Çã°æ(¿¬¼¼´ë ½Å°æ°ú)
-
14:40-15:10 Poster Viewing
  Symposium II
 
Social issues of sleep medicine
ÁÂÀå:±èÁÖÇÑ(ÇѾç´ë ½Å°æ°ú)
Narcolepsy and hypersomnia
ÁÂÀå:À±Áø»ó(Àü³²´ë Á¤½Å°ú)
Recent issues in leep bruxism treatment
ÁÂÀå:Á¤Áø¿ì(¼­¿ï´ë ±¸°­³»°ú)
15:10-15:30 Social issue of narcolepsy
¢¹ Á¤»ó±Ù(ÀüºÏ´ë Á¤½Å°ú)
Narcolepsy update
¢¹ È«½ÂºÀ(¼º±Õ°ü´ë ½Å°æ°ú)
Overviw of bruxism
¢¹ Takafumi Kato(Osaka University)
15:30-15:50 Àü°øÀÇ ¼ö¸é½ÇÅÂÁ¶»ç
¢¹ ±è¿øÁÖ(¿¬¼¼´ë ½Å°æ°ú)
Narcolepsy as an autoimmune disease
¢¹ È«½Âö(°¡Å縯´ë Á¤½Å°ú)
Update on clinical features and management of sleep bruxism
¢¹ Á¤Áø¿ì(¼­¿ï´ë ±¸°­³»°ú)
15:50-16:10 ±³Åë¾ÈÀüÀ» À§ÇÑ ¼ö¸é¹«È£ÈíÁõ ¿îÀüÀÚ °ü¸®¹æ¾È
¢¹ ¹Ú»ó±Ç(±³Åë¾ÈÀü¿¬±¸¿ø)
Treatment of narcolepsy: current and future
¢¹ ³²Çö¿ì(¼­¿ï´ë ½Å°æ°ú)
New approach to bruxism treatment
¢¹ ±è¼ºÅÃ(¿¬¼¼´ë ±¸°­³»°ú)
Other hypersomnia
¢¹ ÀÌÇâ¿î(ÀÌ´ë ½Å°æ°ú)
16:10-16:30
Åä·Ð
Åä·Ð
Åä·Ð
  Symposium III
 
Evidence-based results of surgical approach in OSA
ÁÂÀå:±¸¼ö±Ç
(ºÎ»ê¼º¸ðº´¿ø À̺ñÀÎÈÄ°ú)
Restless legs syndrome
ÁÂÀå:ÀÌ»ó¾Ï(¿ï»ê´ë ½Å°æ°ú)
Pediatric sleep disorders
ÁÂÀå:¾çâ±¹
(ºÎ»ê¼ö¸é¼¾ÅÍ Á¤½Å°ú)
16:30-17:45 Clinical efficacy of palatal surgery - traditional UPPP & minimal invasive palatal surgery
¢¹ ¹ÚÂù¼ø(°¡Å縯´ë À̺ñÀÎÈÄ°ú)
Prevalence of RLS in Korea
¢¹ À±Àοµ(¼­¿ï´ë Á¤½Å°ú)
Age-related changes in sleep/wake patterns of Korean students
¢¹ ¾çâ±¹(ºÎ»ê¼ö¸é¼¾ÅÍ Á¤½Å°ú)
16:45-17:00 Importance of nasal surgery in OSA treatment
¢¹ ±èÈ¿¿­(¼º±Õ°ü´ë À̺ñÀÎÈÄ°ú)
RLS mimics
¢¹ ½Å¿øö(°æÈñ´ë ½Å°æ°ú)
SleepwalkingÀÇ ÃֽŠÁö°ß
¢¹ ä±Ô¿µ(ºÐ´çÂ÷º´¿ø ¼Ò¾Æ°ú)
17:00-17:15 Effect of skeletal surgery in OSA
¢¹ ±è¼º¿Ï(°æÈñ´ë À̺ñÀÎÈÄ°ú)
Treatment of RLS in patients with depression
¢¹ ±è¼º¿Ï(Àü³²´ë Á¤½Å°ú)
ADHD¿Í ¼ö¸éÀå¾Ö
¢¹ ¼º¾ç¼÷(¹Ì¼ÒÁøÁ¤½Å°ú Á¤½Å°ú)
17:15-17:30 Impact of surgical approach on postoperative CPAP therapy in OSA
¢¹ Á¤À¯»ï(¿ï»ê´ë À̺ñÀÎÈÄ°ú)
RLS treatment other than dopamine agonist
¢¹ Á¶¿ë¿ø(°è¸í´ë ½Å°æ°ú)
OSA in children
¢¹ À̹®¼÷(ºÎ»ê¼¼¸íº´¿ø Á¤½Å°ú)
17:30-17:50
Åä·Ð
Åä·Ð
Åä·Ð